Last reviewed · How we verify
flu matrix peptide p58-66 — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
flu matrix peptide p58-66 (flu matrix peptide p58-66) — Baylor Health Care System.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| flu matrix peptide p58-66 TARGET | flu matrix peptide p58-66 | Baylor Health Care System | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- flu matrix peptide p58-66 CI watch — RSS
- flu matrix peptide p58-66 CI watch — Atom
- flu matrix peptide p58-66 CI watch — JSON
- flu matrix peptide p58-66 alone — RSS
Cite this brief
Drug Landscape (2026). flu matrix peptide p58-66 — Competitive Intelligence Brief. https://druglandscape.com/ci/flu-matrix-peptide-p58-66. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab